TRIDENT Preclinical Trials
Multi-site, transformative preclinical evaluation of novel therapeutics through a federal $24M New Frontiers In Research grant.
Check out our website tridentpreclinicaltrials.org for more information or email info@tridentpreclinicaltrial.org!
- Touchscreencognition.org is a revolutionary knowledge mobilization platform for the world-wide community of touchscreen users, the touchscreen-curious and anyone just interested in improving the standards of behavioural testing. Check out TSC below, also a TRIDENT partner. #NFRF #neuroscience #brain
- Check out the new preprint below..exciting discoveries showing novel strategies for treating synucleinopathies. #parkinsons #brain #neuroscience #trident #nfrf 👇🌎🗞
- A new preprint led by my colleagues James Choy and Martin Duennwald with grad student extraordinary Ben Rutledge showing how HOP/STIP1 regulates alpha synuclein misfolding with implicarions for #Parkinson’s and other synucleinopathies www.biorxiv.org/content/10.1...
- Amazing work through @hbhlmcgill.bsky.social from leading minds in neuroscience including @lisasaksida.bsky.social @mallarchak.bsky.social @maximoprado.bsky.social and Dr. Tom Durcan, also TRIDENT lead researchers! 🙌🌎🔬🐁
- At #HBHLSymposium2025, experts from @mcgill.ca & @westernubrainscan.bsky.social shared their breakthroughs in non-invasive neurostimulation, iPSC models and circuit-based approaches for epilepsy, ALS & more, as part of the McGill-Western ITN. 🧠🔬 @borismontreal.bsky.social @jclauneuro.bsky.social
- Reposted by TRIDENT Preclinical TrialsAt #HBHLSymposium2025, experts from @mcgill.ca & @westernubrainscan.bsky.social shared their breakthroughs in non-invasive neurostimulation, iPSC models and circuit-based approaches for epilepsy, ALS & more, as part of the McGill-Western ITN. 🧠🔬 @borismontreal.bsky.social @jclauneuro.bsky.social
- Critical research furthering drug discovery from @maximoprado.bsky.social, @lisasaksida.bsky.social, and @mallarchak.bsky.social, also part of TRIDENT! 🙌🌎🔬
- @maximoprado.bsky.social and @mallarchak.bsky.social present their @westernubrainscan.bsky.social supported work on early biomarkers for development and monitoring of effective disease-modifying therapies at the #hbhlsymposium2025. @hbhlmcgill.bsky.social @westernu.bsky.social
- The time is now for scientific start-ups to benefit from #openscience, leading to reduced costs and accelerated development per @richardgold.bsky.social of @consience.bsky.social and TRIDENT. Check out more below! 👇🌎🗞🤝
